These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Computed tomography study of the sigmoid colon: discriminating diagnostic criteria and interobserver correlations]. Lefèvre F; Béot S; Chapuis F; Deneuville M; Gaucher H; Debelle L; Boccaccini H; Bazin C; Régent D J Radiol; 1999 May; 80(5):447-56. PubMed ID: 10372323 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of signs of autoimmune colitis in Lang N; Dick J; Slynko A; Schulz C; Dimitrakopoulou-Strauss A; Sachpekidis C; Enk AH; Hassel JC Immunotherapy; 2019 Jun; 11(8):667-676. PubMed ID: 31088239 [No Abstract] [Full Text] [Related]
7. Longitudinal studies of the Sachpekidis C; Anwar H; Winkler JK; Kopp-Schneider A; Larribere L; Haberkorn U; Hassel JC; Dimitrakopoulou-Strauss A Cancer Immunol Immunother; 2018 Aug; 67(8):1261-1270. PubMed ID: 29872898 [TBL] [Abstract][Full Text] [Related]
8. Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab. Tirumani SH; Ramaiya NH; Keraliya A; Bailey ND; Ott PA; Hodi FS; Nishino M Cancer Immunol Res; 2015 Oct; 3(10):1185-92. PubMed ID: 26100356 [TBL] [Abstract][Full Text] [Related]
9. Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study. Sachpekidis C; Larribere L; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A; Hassel JC Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):386-96. PubMed ID: 25359635 [TBL] [Abstract][Full Text] [Related]
10. Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT. Alabed YZ; Aghayev A; Sakellis C; Van den Abbeele AD Clin Nucl Med; 2015 Nov; 40(11):e528-9. PubMed ID: 26284765 [TBL] [Abstract][Full Text] [Related]
11. Ipilimumab-induced hepatitis on 18F-FDG PET/CT in a patient with malignant melanoma. Raad RA; Pavlick A; Kannan R; Friedman KP Clin Nucl Med; 2015 Mar; 40(3):258-9. PubMed ID: 25290291 [TBL] [Abstract][Full Text] [Related]
12. Toxic megacolon in patients with severe acute colitis: computed tomographic features. Moulin V; Dellon P; Laurent O; Aubry S; Lubrano J; Delabrousse E Clin Imaging; 2011; 35(6):431-6. PubMed ID: 22040786 [TBL] [Abstract][Full Text] [Related]
13. Absolute number of new lesions on Anwar H; Sachpekidis C; Winkler J; Kopp-Schneider A; Haberkorn U; Hassel JC; Dimitrakopoulou-Strauss A Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):376-383. PubMed ID: 29124281 [TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab. Sachpekidis C; Kopp-Schneider A; Hakim-Meibodi L; Dimitrakopoulou-Strauss A; Hassel JC Melanoma Res; 2019 Apr; 29(2):178-186. PubMed ID: 30653029 [TBL] [Abstract][Full Text] [Related]
15. Pembrolizumab-Induced Thyroiditis and Colitis-Presentation and Resolution on Serial FDG PET/CT. Nawwar AA; Searle J; Lyburn ID Clin Nucl Med; 2021 Feb; 46(2):e121-e122. PubMed ID: 32969909 [TBL] [Abstract][Full Text] [Related]
16. Ipilimumab-Induced Organizing Pneumonia on 18F-FDG PET/CT in a Patient With Malignant Melanoma. Raad RA; Kannan R; Madden K; Pavlick A Clin Nucl Med; 2017 Jul; 42(7):e345-e346. PubMed ID: 28481788 [TBL] [Abstract][Full Text] [Related]
17. Flexible Sigmoidoscopy Rather than Colonoscopy Is Adequate for the Diagnosis of Ipilimumab-Associated Colitis. Herlihy JD; Beasley S; Simmelink A; Maddukuri V; Amin A; Kamionek M; Jacobs C; Bossi K; Scobey M South Med J; 2019 Mar; 112(3):154-158. PubMed ID: 30830228 [TBL] [Abstract][Full Text] [Related]
18. Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma. O'Kane GM; Lyons TG; Colleran GC; Ahmad MW; Alken S; Kavanagh EC; Fitzpatrick D; Murray B; Kelly CM Oncol Res Treat; 2014; 37(12):757-60. PubMed ID: 25531722 [TBL] [Abstract][Full Text] [Related]